Skip to content
value.today

Moderna, Inc. vs Orphazyme A/S

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Moderna, Inc. is the larger company by market value: $90.1 B against $7 M for Orphazyme A/S, 12876 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Orphazyme A/S). Orphazyme A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Both made a net loss: $2.8 B for Moderna, Inc. and $101 M for Orphazyme A/S.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0342685102713702020202120222023202420252026Moderna, Inc. 1370Orphazyme A/S 3

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$5B$10B$14B$19B201720182019202020212022202320242025Moderna, Inc. $2B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureModerna, Inc.
MRNA · #275 in the world
Orphazyme A/S
ORPHA.CO
Profile
Country🇺🇸 USA🇩🇰 Denmark
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded2010—
Size
Market cap$90.1 B$7 M*
Revenue$1.9 B$0 M
Net income$-2.8 B$-101 M▲ best
Employees4,700—
Valuation
Price to sales35.7×—
Price to book10.4×—
Free cash flow yield-2.3%—
Profitability
Gross margin55.4%—
Operating margin-158.1%—
Net margin-145.2%—
Return on equity-28.9%—
Growth
Revenue growth-39.9%—
Revenue growth, 3 years a year-53.4%—
Financial strength
Debt to equity0.1×—
Cash
Free cash flow margin-106.2%—
Shareholder returns
Shareholder yield0.0%—
Strength scores
Piotroski F-score3 of 9—
Altman Z-score zonesafe—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Moderna, Inc. or Orphazyme A/S?

Moderna, Inc. is the larger company by market value: $90.1 B against $7 M for Orphazyme A/S, 12876 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Orphazyme A/S). Orphazyme A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Moderna, Inc. or Orphazyme A/S?

Both made a net loss: $2.8 B for Moderna, Inc. and $101 M for Orphazyme A/S.

Sources#

Every figure on this page comes from these, with the date shown next to it.